What does MAVEFAR do?

MAVEFAR is a pharmacy in Villers-le-Bouillet. Private Limited, started on 20 September 2004, 1 establishment.

What is the address of MAVEFAR?

The registered office of MAVEFAR is located at Rue de Waremme 2, 4530 Villers-le-Bouillet.

Is MAVEFAR still active?

Yes. According to the CBE (29 October 2026) MAVEFAR is active, legal situation “Normale toestand”, started on 20 September 2004.

Is MAVEFAR registered on Peppol?

Yes, MAVEFAR is registered on the Peppol network with ID 0208:0867317778.

What is the enterprise number of MAVEFAR?

The enterprise number of MAVEFAR is BE0867317778.

When was MAVEFAR founded?

MAVEFAR was founded on 20 September 2004.

Who are the directors of MAVEFAR?

According to the 2025 annual accounts, the directors of MAVEFAR are: Mathieu VANDERBECKEN.

Is MAVEFAR a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 20 September 2004; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did MAVEFAR make in 2025?

MAVEFAR posted a profit after taxes of € 37,691 in financial year 2025.

What is the revenue of MAVEFAR?

As a small company, MAVEFAR is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 147,700.

MAVEFAR (Private Limited) - Villers-le-Bouillet

Dossier MAVEFAR, printed on 29 October 2026 from databakkes.be/en/0867317778/mavefar. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 16 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

MAVEFAR from Villers-le-Bouillet, company number BE0867317778, closed financial year 2025 with a result of € 37,691 after tax. For that financial year MAVEFAR recorded a gross margin of € 147,700 and equity of € 432,135. Compared with financial year 2024, the result moved from € 5,478 to € 37,691. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 21, 2026.

What it is worth Healthy

€ 432,135

▼ 7% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 37,691

▲ € 32,213 vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 82,069

▼ 44% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 68,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 7,863

▼ 53% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 17 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 230,642

▼ 5% vs 2024

€ 13,375 is repaid this year. At this pace the long-term loan is gone in ≈ 17 years.

Owed to suppliers

€ 5,530

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 10,859

▲ 190% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 87,097 Gross margin 2022: € 87,097 First fiscal year in the series	€ 88,934 Gross margin 2023: € 88,934 ▲ 2% vs 2022 (€ 87,097) Favourable step	€ 76,345 Gross margin 2024: € 76,345 ▼ 14% vs 2023 (€ 88,934) Unfavourable step	€ 147,700 Gross margin 2025: € 147,700 ▲ 93% vs 2024 (€ 76,345) Favourable step	▲ 93%
Profit after taxes	€ 38,068 Profit after taxes 2022: € 38,068 First fiscal year in the series	€ 37,963 Profit after taxes 2023: € 37,963 Unchanged (€ 38,068) Unfavourable step	€ 5,478 Profit after taxes 2024: € 5,478 ▼ 86% vs 2023 (€ 37,963) Unfavourable step	€ 37,691 Profit after taxes 2025: € 37,691 ▲ € 32,213 vs 2024 (€ 5,478) Favourable step	▲ € 32,213
Equity	€ 544,002 Equity 2022: € 544,002 First fiscal year in the series	€ 522,965 Equity 2023: € 522,965 ▼ 4% vs 2022 (€ 544,002) Unfavourable step	€ 462,443 Equity 2024: € 462,443 ▼ 12% vs 2023 (€ 522,965) Unfavourable step	€ 432,135 Equity 2025: € 432,135 ▼ 7% vs 2024 (€ 462,443) Unfavourable step	▼ 7%
Total debts	€ 568,892 Total debts 2022: € 568,892 First fiscal year in the series	€ 593,341 Total debts 2023: € 593,341 ▲ 4% vs 2022 (€ 568,892) Unfavourable step	€ 841,168 Total debts 2024: € 841,168 ▲ 42% vs 2023 (€ 593,341) Unfavourable step	€ 779,022 Total debts 2025: € 779,022 ▼ 7% vs 2024 (€ 841,168) Favourable step	▼ 7%
Cash	€ 174,940 Cash 2022: € 174,940 First fiscal year in the series	€ 102,241 Cash 2023: € 102,241 ▼ 42% vs 2022 (€ 174,940) Unfavourable step	€ 146,132 Cash 2024: € 146,132 ▲ 43% vs 2023 (€ 102,241) Favourable step	€ 82,069 Cash 2025: € 82,069 ▼ 44% vs 2024 (€ 146,132) Unfavourable step	▼ 44%
Land & buildings	-	-	€ 306,817 Land & buildings 2024: € 306,817 First fiscal year in the series	€ 272,491 Land & buildings 2025: € 272,491 ▼ 11% vs 2024 (€ 306,817) Unchanged	▼ 11%
Retained profit	€ 525,402 Retained profit 2022: € 525,402 First fiscal year in the series	€ 504,365 Retained profit 2023: € 504,365 ▼ 4% vs 2022 (€ 525,402) Unfavourable step	€ 443,843 Retained profit 2024: € 443,843 ▼ 12% vs 2023 (€ 504,365) Unfavourable step	€ 413,535 Retained profit 2025: € 413,535 ▼ 7% vs 2024 (€ 443,843) Unfavourable step	▼ 7%
Dividend	€ 101,500 Dividend 2022: € 101,500 First fiscal year in the series	€ 59,000 Dividend 2023: € 59,000 ▼ 42% vs 2022 (€ 101,500) Unchanged	€ 66,000 Dividend 2024: € 66,000 ▲ 12% vs 2023 (€ 59,000) Unchanged	€ 68,000 Dividend 2025: € 68,000 ▲ 3% vs 2024 (€ 66,000) Unchanged	▲ 3%
Bank debt	€ 25,907 Bank debt 2022: € 25,907 First fiscal year in the series	€ 12,390 Bank debt 2023: € 12,390 ▼ 52% vs 2022 (€ 25,907) Favourable step	€ 243,554 Bank debt 2024: € 243,554 ▲ € 231,164 vs 2023 (€ 12,390) Unfavourable step	€ 230,642 Bank debt 2025: € 230,642 ▼ 5% vs 2024 (€ 243,554) Favourable step	▼ 5%
Balance sheet total	€ 1,112,894 Balance sheet total 2022: € 1,112,894 First fiscal year in the series	€ 1,116,306 Balance sheet total 2023: € 1,116,306 Unchanged (€ 1,112,894) Unchanged	€ 1,303,611 Balance sheet total 2024: € 1,303,611 ▲ 17% vs 2023 (€ 1,116,306) Unchanged	€ 1,211,157 Balance sheet total 2025: € 1,211,157 ▼ 7% vs 2024 (€ 1,303,611) Unchanged	▼ 7%

Key figures of MAVEFAR, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to MAVEFAR?

What happened at MAVEFAR in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

May 21, 2026 New annual accounts for financial year 2025: profit of € 37,691 (▲ € 32,213 vs 2024). Source: NBB ↗
Oct 1, 2004 New establishment in Villers-le-Bouillet. KBO
Sep 20, 2004 Start of the company according to the CBE. KBO

In short

From € 38,068 profit in 2022 to € 37,691 profit in 2025.

Paid € 53,225 in corporate taxes since 2022.

Best year ever: 2022, with € 38,068 profit.

Paid out € 294,500 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Mathieu VANDERBECKEN

MAVEFAR

Pharmacie ROLAND 99.7%

Behind MAVEFAR is Mathieu VANDERBECKEN. It owns 99.7% of Pharmacie ROLAND itself.

Directors

According to the 2025 annual accounts

Mathieu VANDERBECKEN

Director

Also active at: Régie Communale Autonome "Agence de développement local"

Establishments

Establishment units

Physical locations of this company

Registered office

Rue de Waremme 2

4530 Villers-le-Bouillet

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

Pharmacie Roland same network

€ 423,712 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0867.317.778

VAT number

BE 0867.317.778

Registered office

Rue de Waremme 2, 4530 Villers-le-Bouillet

Names & denominations

MAVEFAR

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

20 September 2004

Peppol

Active · Active since 4 Nov 2025

Activities · NACE

Detailhandel in farmaceutische producten

Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen

Verhuur en exploitatie van eigen of geleased residentieel onroerend goed, exclusief sociale woningen

Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels

View on CBE Public ↗ Annual accounts (NBB) ↗

MAVEFAR

Warning lights

Financials

What happened to MAVEFAR?

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions